Skip to Main Content

Paper Details

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
Genet Med
49
2020
Acute coronary syndrome, CVD, CYP2C19, CYP2C9, PGx, PGx panel, VKORC1, atrial fibrillation, cardiovascular disease, cardiovascular diseases, clopidogrel, warfarin
Author NameAffiliation
Zhen WangRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic
Zhen WangMayo Clinic
Suzette J BielinskiMayo Clinic
Suzette J BielinskiMayo Clinic
Liewei WangMayo Clinic
Richard M WeinshilboumMayo Clinic
  • 1 - 6

Datasets

Release 1.2